Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000907303-05-000017
Filing Date
2005-01-26
Accepted
2005-01-26 16:01:06
Documents
1
Period of Report
2005-01-24

Document Format Files

Seq Description Document Type Size
1 form4alandfrazierjan2005_ex.html 4  
1 form4alandfrazierjan2005_ex.xml 4 9324
  Complete submission text file 0000907303-05-000017.txt   11018
Mailing Address
Business Address 8271 154TH AVENUE NE REDMOND WA 98052
FRAZIER ALAN D (Reporting) CIK: 0001018534 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-29889 | Film No.: 05550167

Mailing Address 1180 VETERANS BOULEVARD SOUTH SAN FRANCISCO CA 94080
Business Address 1180 VETERANS BOULEVARD SOUTH SAN FRANCISCO CA 94080
RIGEL PHARMACEUTICALS INC (Issuer) CIK: 0001034842 (see all company filings)

EIN.: 943248524 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations